How to Know If Your GLP-1 Telehealth Provider Is Legitimate

The GLP-1 telehealth market exploded from a handful of providers in 2023 to hundreds in 2026. Most are legitimate medical operations. Some are not. The FDA's enforcement actions against 30+ telehealth companies in March 2026 — and the subsequent DOJ referrals — revealed serious quality control failures at some compounding operations.

This guide helps you evaluate whether your current or prospective GLP-1 provider meets basic safety standards.

The 8-Point Provider Verification Checklist

1. Licensed Physicians, Not "Wellness Coaches"

Your prescription should come from a physician (MD or DO), nurse practitioner (NP), or physician assistant (PA) licensed in your state. Verify their license at your state medical board's website. If the provider won't tell you who prescribed your medication, that's a red flag.

2. Proper Medical Intake

A legitimate provider asks about your medical history, current medications, allergies, and contraindications before prescribing. If you received a GLP-1 prescription without any health screening, the provider cut corners on safety.

3. 503A-Licensed Compounding Pharmacy

If you're receiving compounded medication, ask whether it comes from a 503A (patient-specific) or 503B (outsourcing facility) pharmacy. With the FDA's proposed 503B Bulks List exclusion, 503A sourcing is the more durable pathway. Either way, the pharmacy should be licensed by its state board of pharmacy.

4. Proper Labeling and Dosing

Your medication should arrive with clear labeling showing: the active ingredient and concentration, the compounding pharmacy's name and license number, your name and prescription details, storage instructions, and an expiration date. Multi-dose vials should include clear instructions on how to draw the correct dose.

5. Cold Chain Shipping

Injectable GLP-1 medications (both brand and compounded) require refrigeration or cold-chain shipping. If your medication arrived in a padded envelope with no cold pack during warm weather, the product may have been compromised.

6. Follow-Up Care

Legitimate providers offer ongoing check-ins, dose adjustments, and side effect management. A provider that mails you medication and disappears until your next refill is providing a product, not healthcare.

7. Transparent Pricing

You should know exactly what you're paying for before committing. Hidden fees, auto-renewals without consent, and "processing charges" that appear after sign-up are warning signs.

8. LegitScript Certification (Bonus)

LegitScript is an independent verification service that evaluates healthcare websites for legal and safety compliance. While not all legitimate providers have this certification, those that do have undergone third-party scrutiny.

What the Adverse Event Data Tells Us

The 775+ adverse events reported to the FDA aren't proof that all compounded GLP-1s are dangerous. Many reports involved specific problems that proper pharmacy practices would prevent:

• Dosing errors — Patients drawing incorrect amounts from multi-dose vials, sometimes resulting in significantly higher doses than intended
• Contamination — Improperly prepared sterile injectables
• Wrong concentrations — Pharmacies dispensing vials with inconsistent drug concentrations
• Counterfeit products — Products sold as "compounded semaglutide" that contained little or no active ingredient

The common thread: these problems occur at low-quality compounding operations, not at properly licensed and inspected 503A pharmacies with robust quality control.